Copyright © 2002 by the European Society of Cardiology.
An economic analysis of specialist heart failure nurse management in the U.K. Can we afford not to implement it?
a Department of Cardiology, The Queen Elizabeth Hospital/University of Adelaide, Australia
b the Clinical Research Initiative in Heart Failure, University of Glasgow, Glasgow, Scotland
c Greater Glasgow Health Board, Glasgow, Scotland, U.K.
revised November 27, 2001; accepted November 28, 2001
Abstract
Aims Hospital activity represents the major component of health care expenditure related to heart failure. This study evaluated the economic impact of applying specialist nurse management programmes that limit heart failure-related hospital readmissions within a whole population.
Methods Using a reliable and validated estimate of the current level and cost of heart failure-related hospital activity in the U.K., we determined the thresholds at which the actual cost of establishing and applying a national service based on three different models of specialist nurse management would be equal to the cost of bed utilization associated with preventable hospital readmissions in the year 2000. The three models of care examined were home-based, clinic-based or a combination of home plus clinic-based, post-discharge follow-up. The potential impact of this service was based on a U.K.-wide caseload of 122000 patients discharged to home with a discharge diagnosis of congestive heart failure in that year.
Results Based on heart failure-specific patterns of hospital activity, we estimate that 47000 of these 122000 patients would normally accumulate a total of 594000 days of associated hospital stay from 49000 readmissions (for any reason) within 1 year of hospital discharge. The cost of these admissions to the National Health Service was calculated at £166·2 million. Taking into account other costs associated with such hospital activity (e.g. general practice and hospital outpatient visits) each 10% reduction in recurrent bed utilization would be associated with £18·0 million in cost savings. Alternatively, the cost of applying a U.K.-wide programme of home-, clinic- or home plus clinic-based follow-up was calculated to be £69·4, £73·1 and £72·5 million per annum, respectively. The relative thresholds at which generated cost-savings would equal the cost of applying these programmes of care would therefore be a 38·5%, 40·6% and 40·3% reduction in recurrent bed utilization, respectively. If, as expected, a home-based programme of specialist nurse management reduced recurrent bed utilization by 50% or more, annual savings equivalent to £169000 per 1000 patients treated would be generated.
Conclusions This is the first study to examine the economic consequences of applying a specialist nurse-mediated, post-discharge management service for heart failure within a whole population. Our findings suggest that such a service will not only improve quality of life and reduce readmissions in patients with congestive heart failure, but also reduce costs and improve the efficiency of the health care system in doing so. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Key Words: Heart failure, cost evaluation, morbidity, hospitalization, nurse intervention
f1 Correspondence: Professor John McMurray, CRI in Heart Failure, Wolfson Building, University of Glasgow, Glasgow, U.K.
References
- Kelly D. Our future society: A global challenge. Circulation. 1997;95:24592464
[Free Full Text] - Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:15471557[CrossRef][ISI][Medline]
- Capewell S, Livingstone BM, MacIntyre K. Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J. 2001;21:18331840
- Bonneux L, Barendregt MA, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: The future rise of heart failure. Am J Public Health. 1994;84:2028
[Abstract/Free Full Text] - Stewart, S, MacIntyre, K, Capewell, S, McMurray, JJV, An ageing population and heart failure: An increasing burden in the 21st Century?, Heart
- Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: national hospital discharge survey 19851995. Am Heart J. 1999;137:352360[CrossRef][ISI][Medline]
- Reitsma JB, Mosterd A, de Craen AJM. Increase in hospital admission rates for heart failure in the Netherlands, 19801993. Heart. 1996;76:388392
[Abstract/Free Full Text] - Rodriguez-Artalejo F, Guallar-Castillon P, Banegas Banegas JR, del Rey Calero J. Trends in hospitalization and mortality for heart failure in Spain, 19801993. Eur Heart J. 1997;18:17711779
[Abstract/Free Full Text] - McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 19801990. Eur Heart J. 1993;14:11581162
[Abstract/Free Full Text] - Stewart S, MacIntyre K, McCleod MC, Bailey AE, McMurray JJV. Trends in heart failure hospitalizations in Scotland, 19901996: An epidemic that has reached its peak? Eur Heart J. 2000;22:209217
- McMurray JJ, Stewart S. Epidemiology, aetiology and prognosis of heart failure. Heart. 2000;83:596602
[Free Full Text] - Stewart S, Jenkins A, Buchan S, Capewell S, McGuire A, McMurray JJ. The current cost of heart failure in the UKAn economic analysis. Eur J Heart Fail. 2002;:
- McMurray JJ, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ. 1993;6:9198
- Packer M, Poole-Wilson PA, Armstrong PW. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:23122318
[Abstract/Free Full Text] - Packer M, Coats AJS, Fowler MB. Effect of Carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:16511658
[Abstract/Free Full Text] - Horowitz JD. Home-based intervention: the next step in treatment of chronic heart failure? Eur Heart J. 2000;21:18071809
[Free Full Text] - Mark DB. Economics of treating heart failure. Am J Cardiol. 1997;80:33H38H[CrossRef][Medline]
- Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:11901195
[Abstract/Free Full Text] - Stewart S, Vandenbroek A, Pearson S, Horowitz J. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among congestive heart failure patients. Arch Intern Med. 1999;159:257261
[Abstract/Free Full Text] - Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomized controlled study. Lancet. 1999;354:10771083[CrossRef][ISI][Medline]
- Cline C, Israelsson B, Willenheimer R. A cost effective management program for heart failure reduces hospitalization. Heart. 1998;80:442446
[Abstract/Free Full Text] - Doughty RN, Wright SP, Walsh HJ. Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. Eur Heart J. 2002;23:139146
[Abstract/Free Full Text] - Blue L, Strong E, Murdoch DR. Improving long-term outcome with specialist nurse intervention in heart failure: a randomized trial. BMJ. 2001;323:715718
[Abstract/Free Full Text] - Naylor MD, Brooten D, Cambell R. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA. 1999;281:613620
[Abstract/Free Full Text] - Moser DK, Macko MJ, Worster P. Community case management decreases rehospitalization rates and costs, and improves quality of life in heart failure patients with preserved and non-preserved left ventricular function: A randomized controlled trial. Circulation. 2000;102:II749
- Krumholz HM, Amatruda J, Mattera JA. Randomized trial of a nurse-directed educational intervention to prevent readmission of patients with heart failure. Circulation. 2000;102:II749
- Jaarsma T, Halfens R, Huijer Abu-Saad H. Effects of education and support on self-care and resource utilization in patients with heart failure. Eur Heart J. 1999;20:673682
[Abstract/Free Full Text] - Petrie M, Berry C, Stewart S, McMurray JJV. Older hearts in failure. Eur Heart J. 2001;22:19781990
[Free Full Text] - Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of heart failure. Eur Heart J. 2001;22:15271560
[Free Full Text] - http://www.doh.gov.uk/nsf/
- National Health Service in Scotland, Scottish Health Service Costs (year ending March 2000), Edinburgh, Information and Statistics Division, 2000
- Office of Health Economics, 10th Compendium of Health Statistics, London, Office of Health Economics, 1997
- IMS Health, Congestive heart failure, 2000
- West J, Miller N, Parker K, Senneca D. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997;79:5863[CrossRef][ISI][Medline]
- Fonarow GC, Stevenson LW, Walden JA. Impact of a comprehensive heart failure management program on hospital readmissions and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725732[Abstract]
- McMurray JJV, Stewart S. Nurse-led multidisciplinary, intervention in chronic heart failure. Heart. 1998;80:430431
[Free Full Text] - Stewart S, Blue L. Improving outcomes in chronic heart failure with specialist nurse intervention: A practical guide. London: BMA Publishers; 2000.
- Ekman I, Andersson B, Ehnfors M, Matejka G, Persson B, Fagerberg B. Feasibility of a nurse-monitored, outpatient program for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J. 1998;19:12541260
[Abstract/Free Full Text] - Strömberg A. Heart failure clinics (editorial). Heart. 1998;80:426427
[Free Full Text] - Tengs TO, Adams ME, Pliskin JS. Five hundred life saving interventions and their cost-effectiveness. Risk Anal. 1995;15:369390[CrossRef][ISI][Medline]
- McMurray JJ, Davie A. The pharmacoeconomics of ACE inhibitors in chronic heart failure. Pharmacoeconomics. 1996;9:188197[ISI][Medline]
- Paul SD, Kuntz KM, Eagle KA, Weinstein MC. Costs and effectiveness of angiotensin converting enzyme inhibitors in patients with congestive heart failure. Arch Intern Med. 1994;154:11431149[Abstract]
- Eur Heart J. 2001;22:10211031
[Abstract/Free Full Text] - Stewart S, Blue L, Capewell S, Horowitz JD, McMurray JJV. Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure. Eur J Heart Fail. 2001;3:249255[CrossRef][ISI][Medline]
- MacIntyre K, Capewell S, Stewart S. Evidence of improving prognosis in heart failure: Trends in case-fatality in 66547 patients hospitalised between 1986 and 1995. Circulation. 2000;102:11261131
[Abstract/Free Full Text] - Stewart S, MacIntyre K, Hole DA, Capewell S, McMurray JJV. More malignant than cancer? Five-year survival following a first admission for heart failure in Scotland? Eur J Heart Fail. 2001;3:315322[CrossRef][ISI][Medline]
This article has been cited by other articles:
![]() |
GESICA Investigators Randomised trial of telephone intervention in chronic heart failure: DIAL trial BMJ, August 20, 2005; 331(7514): 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J Leslie, S P McKee, E A Imray, and M A Denvir Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract Postgrad. Med. J., May 1, 2005; 81(955): 321 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gonseth, P. Guallar-Castillon, J. R. Banegas, and F. Rodriguez-Artalejo The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports Eur. Heart J., September 2, 2004; 25(18): 1570 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Covolo, U. Gelatti, M. Metra, S. Nodari, A. Piccichè, N. Pezzali, C. Zani, A. Alberti, F. Donato, G. Nardi, et al. Role of {beta}1- and {beta}2-adrenoceptor polymorphisms in heart failure: a case-control study Eur. Heart J., September 1, 2004; 25(17): 1534 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, S. Stewart, S. Ferrua, and J. J.J.V. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials J. Am. Coll. Cardiol., August 18, 2004; 44(4): 810 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stromberg, J. Martensson, B. Fridlund, L-A Levin, J.-E. Karlsson, and U. Dahlstrom Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: Results from a prospective, randomised trial Eur. Heart J., June 1, 2003; 24(11): 1014 - 1023. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



